Correlation Between Harmony Biosciences and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Harmony Biosciences and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harmony Biosciences and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Harmony Biosciences Holdings and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Harmony Biosciences and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harmony Biosciences with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harmony Biosciences and Syndax Pharmaceuticals.
Diversification Opportunities for Harmony Biosciences and Syndax Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Harmony and Syndax is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Harmony Biosciences Holdings and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Harmony Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harmony Biosciences Holdings are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Harmony Biosciences i.e., Harmony Biosciences and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Harmony Biosciences and Syndax Pharmaceuticals
Given the investment horizon of 90 days Harmony Biosciences Holdings is expected to generate 0.35 times more return on investment than Syndax Pharmaceuticals. However, Harmony Biosciences Holdings is 2.84 times less risky than Syndax Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 3,380 in Harmony Biosciences Holdings on August 31, 2024 and sell it today you would earn a total of 195.00 from holding Harmony Biosciences Holdings or generate 5.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Harmony Biosciences Holdings vs. Syndax Pharmaceuticals
Performance |
Timeline |
Harmony Biosciences |
Syndax Pharmaceuticals |
Harmony Biosciences and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Harmony Biosciences and Syndax Pharmaceuticals
The main advantage of trading using opposite Harmony Biosciences and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harmony Biosciences position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Harmony Biosciences vs. Keros Therapeutics | Harmony Biosciences vs. Janux Therapeutics | Harmony Biosciences vs. Fennec Pharmaceuticals | Harmony Biosciences vs. Edgewise Therapeutics |
Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |